Zebrafish as a model to understand autophagy and its role in neurological disease

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1812, Issue 4, 2011, Pages 520-526

  Fleming, Angeleen ^a,b   Rubinsztein, David C ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Autophagy; Neurodegeneration; Zebrafish

Indexed keywords

AUTOPHAGY; DEGENERATIVE DISEASE; EMBRYO DEVELOPMENT; EUKARYOTIC CELL; GENETIC MANIPULATION; LOSS OF FUNCTION MUTATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PHAGOSOME; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN DEGRADATION; REVIEW; ZEBRA FISH;

ANIMALS; AUTOPHAGY; DISEASE MODELS, ANIMAL; HUMANS; NEURODEGENERATIVE DISEASES; ZEBRAFISH;

DANIO RERIO; EUKARYOTA; VERTEBRATA;

EID: 79751535178     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2011.01.004     Document Type: Review

References (91)

1. Tettamanti G., Salo E., Gonzalez-Estevez C., Felix D.A., Grimaldi A., de Eguileor M. Autophagy in invertebrates: insights into development, regeneration and body remodeling. Curr. Pharm. Des. 2008, 14:116-125.
2. Dooley K., Zon L.I. Zebrafish: a model system for the study of human disease. Curr. Opin. Genet. Dev. 2000, 10:252-256.
3. Ingham P.W. The power of the zebrafish for disease analysis. Hum. Mol. Genet. 2009, 18:R107-R112.
4. Linney E., Hardison N.L., Lonze B.E., Lyons S., DiNapoli L. Transgene expression in zebrafish: a comparison of retroviral-vector and DNA-injection approaches. Dev. Biol. 1999, 213:207-216.
5. Asakawa K., Kawakami K. Targeted gene expression by the Gal4-UAS system in zebrafish. Dev. Growth Differ. 2008, 50:391-399.
6. Soroldoni D., Hogan B.M., Oates A.C. Simple and efficient transgenesis with meganuclease constructs in zebrafish. Methods Mol. Biol. 2009, 546:117-130.
7. Suster M.L., Kikuta H., Urasaki A., Asakawa K., Kawakami K. Transgenesis in zebrafish with the tol2 transposon system. Methods Mol. Biol. 2009, 561:41-63.
8. Williams A., Sarkar S., Cuddon P., Ttofi E.K., Saiki S., Siddiqi F.H., Jahreiss L., Fleming A., Pask D., Goldsmith P., O'Kane C.J., Floto R.A., Rubinsztein D.C. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 2008, 4:295-305.
9. Tomasiewicz H.G., Flaherty D.B., Soria J.P., Wood J.G. Transgenic zebrafish model of neurodegeneration. J. Neurosci. Res. 2002, 70:734-745.
10. Bai Q., Garver J.A., Hukriede N.A., Burton E.A. Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene. Nucleic Acids Res. 2007, 35:6501-6516.
11. Paquet D., Bhat R., Sydow A., Mandelkow E.M., Berg S., Hellberg S., Falting J., Distel M., Koster R.W., Schmid B., Haass C. A zebrafish model of tauopathy allows in vivo imaging of neuronal cell death and drug evaluation. J. Clin. Invest. 2009, 119:1382-1395.
12. Ramesh T., Lyon A.N., Pineda R.H., Wang C., Janssen P.M., Canan B.D., Burghes A.H., Beattie C.E. A genetic model of amyotrophic lateral sclerosis in zebrafish displays phenotypic hallmarks of motoneuron disease. Dis. Model Mech. 2010, 3:652-662.
13. Wen L., Wei W., Gu W., Huang P., Ren X., Zhang Z., Zhu Z., Lin S., Zhang B. Visualization of monoaminergic neurons and neurotoxicity of MPTP in live transgenic zebrafish. Dev. Biol. 2008, 314:84-92.
14. Miller V.M., Nelson R.F., Gouvion C.M., Williams A., Rodriguez-Lebron E., Harper S.Q., Davidson B.L., Rebagliati M.R., Paulson H.L. CHIP suppresses polyglutamine aggregation and toxicity in vitro and in vivo. J. Neurosci. 2005, 25:9152-9161.
15. Schiffer N.W., Broadley S.A., Hirschberger T., Tavan P., Kretzschmar H.A., Giese A., Haass C., Hartl F.U., Schmid B. Identification of anti-prion compounds as efficient inhibitors of polyglutamine protein aggregation in a zebrafish model. J. Biol. Chem. 2007, 282:9195-9203.
16. Lemmens R., Van Hoecke A., Hersmus N., Geelen V., D'Hollander I., Thijs V., Van Den Bosch L., Carmeliet P., Robberecht W. Overexpression of mutant superoxide dismutase 1 causes a motor axonopathy in the zebrafish. Hum. Mol. Genet. 2007, 16:2359-2365.
17. Kabashi E., Lin L., Tradewell M.L., Dion P.A., Bercier V., Bourgouin P., Rochefort D., Bel Hadj S., Durham H.D., Vande Velde C., Rouleau G.A., Drapeau P. Gain and loss of function of ALS-related mutations of TARDBP (TDP-43) cause motor deficits in vivo. Hum. Mol. Genet. 2010, 19:671-683.
18. Laird A.S., Van Hoecke A., De Muynck L., Timmers M., Van den Bosch L., Van Damme P., Robberecht W. Progranulin is neurotrophic in vivo and protects against a mutant TDP-43 induced axonopathy. PLoS ONE 2010, 5:e13368.
19. Chitramuthu B.P., Baranowski D.C., Kay D.G., Bateman A., Bennett H.P. Progranulin modulates zebrafish motoneuron development in vivo and rescues truncation defects associated with knockdown of Survival motor neuron 1. Mol. Neurodegener 2010, 5:41.
20. Guo S. Using zebrafish to assess the impact of drugs on neural development and function. Expert Opin. Drug Discov. 2009, 4:715-726.
21. Eisen J.S., Smith J.C. Controlling morpholino experiments: don't stop making antisense. Development 2008, 135:1735-1743.
22. Wickstrom E., Urtishak K.A., Choob M., Tian X., Sternheim N., Cross L.M., Rubinstein A., Farber S.A. Downregulation of gene expression with negatively charged peptide nucleic acids (PNAs) in zebrafish embryos. Methods Cell Biol. 2004, 77:137-158.
23. Tomasini A.J., Schuler A.D., Zebala J.A., Mayer A.N. PhotoMorphs: a novel light-activated reagent for controlling gene expression in zebrafish. Genesis 2009, 47:736-743.
24. Bretaud S., Allen C., Ingham P.W., Bandmann O. p53-dependent neuronal cell death in a DJ-1-deficient zebrafish model of Parkinson's disease. J. Neurochem. 2007, 100:1626-1635.
25. Anichtchik O., Diekmann H., Fleming A., Roach A., Goldsmith P., Rubinsztein D.C. Loss of PINK1 function affects development and results in neurodegeneration in zebrafish. J. Neurosci. 2008, 28:8199-8207.
26. Flinn L., Mortiboys H., Volkmann K., Koster R.W., Ingham P.W., Bandmann O. Complex I deficiency and dopaminergic neuronal cell loss in parkin-deficient zebrafish (Danio rerio). Brain 2009, 132:1613-1623.
27. Xi Y., Ryan J., Noble S., Yu M., Yilbas A.E., Ekker M. Impaired dopaminergic neuron development and locomotor function in zebrafish with loss of pink1 function. Eur. J. Neurosci. 2010, 31:623-633.
28. Sheng D., Qu D., Kwok K.H., Ng S.S., Lim A.Y., Aw S.S., Lee C.W., Sung W.K., Tan E.K., Lufkin T., Jesuthasan S., Sinnakaruppan M., Liu J. Deletion of the WD40 domain of LRRK2 in zebrafish causes Parkinsonism-like loss of neurons and locomotive defect. PLoS Genet. 2010, 6:e1000914.
29. Sallinen V., Kolehmainen J., Priyadarshini M., Toleikyte G., Chen Y.C., Panula P. Dopaminergic cell damage and vulnerability to MPTP in Pink1 knockdown zebrafish. Neurobiol. Dis. 2010, 40:93-101.
30. Gros-Louis F., Kriz J., Kabashi E., McDearmid J., Millecamps S., Urushitani M., Lin L., Dion P., Zhu Q., Drapeau P., Julien J.P., Rouleau G.A. Als2 mRNA splicing variants detected in KO mice rescue severe motor dysfunction phenotype in Als2 knock-down zebrafish. Hum. Mol. Genet. 2008, 17:2691-2702.
31. McWhorter M.L., Monani U.R., Burghes A.H., Beattie C.E. Knockdown of the survival motor neuron (Smn) protein in zebrafish causes defects in motor axon outgrowth and pathfinding. J. Cell Biol. 2003, 162:919-931.
32. Winkler C., Eggert C., Gradl D., Meister G., Giegerich M., Wedlich D., Laggerbauer B., Fischer U. Reduced U snRNP assembly causes motor axon degeneration in an animal model for spinal muscular atrophy. Genes Dev. 2005, 19:2320-2330.
33. Boon K.L., Xiao S., McWhorter M.L., Donn T., Wolf-Saxon E., Bohnsack M.T., Moens C.B., Beattie C.E. Zebrafish survival motor neuron mutants exhibit presynaptic neuromuscular junction defects. Hum. Mol. Genet. 2009, 18:3615-3625.
34. Lumsden A.L., Henshall T.L., Dayan S., Lardelli M.T., Richards R.I. Huntingtin-deficient zebrafish exhibit defects in iron utilization and development. Hum. Mol. Genet. 2007, 16:1905-1920.
35. Diekmann H., Anichtchik O., Fleming A., Futter M., Goldsmith P., Roach A., Rubinsztein D.C. Decreased BDNF levels are a major contributor to the embryonic phenotype of huntingtin knockdown zebrafish. J. Neurosci. 2009, 29:1343-1349.
36. Futter M., Diekmann H., Schoenmakers E., Sadiq O., Chatterjee K., Rubinsztein D.C. Wild-type but not mutant huntingtin modulates the transcriptional activity of liver X receptors. J. Med. Genet. 2009, 46:438-446.
37. Henshall T.L., Tucker B., Lumsden A.L., Nornes S., Lardelli M.T., Richards R.I. Selective neuronal requirement for huntingtin in the developing zebrafish. Hum. Mol. Genet. 2009, 18:4830-4842.
38. Krawitz P., Haffner C., Fluhrer R., Steiner H., Schmid B., Haass C. Differential localization and identification of a critical aspartate suggest non-redundant proteolytic functions of the presenilin homologues SPPL2b and SPPL3. J. Biol. Chem. 2005, 280:39515-39523.
39. Campbell W.A., Yang H., Zetterberg H., Baulac S., Sears J.A., Liu T., Wong S.T., Zhong T.P., Xia W. Zebrafish lacking Alzheimer presenilin enhancer 2 (Pen-2) demonstrate excessive p53-dependent apoptosis and neuronal loss. J. Neurochem. 2006, 96:1423-1440.
40. Zetterberg H., Campbell W.A., Yang H.W., Xia W. The cytosolic loop of the gamma-secretase component presenilin enhancer 2 protects zebrafish embryos from apoptosis. J. Biol. Chem. 2006, 281:11933-11939.
41. Nornes S., Newman M., Verdile G., Wells S., Stoick-Cooper C.L., Tucker B., Frederich-Sleptsova I., Martins R., Lardelli M. Interference with splicing of Presenilin transcripts has potent dominant negative effects on Presenilin activity. Hum. Mol. Genet. 2008, 17:402-412.
42. Carrel T.L., McWhorter M.L., Workman E., Zhang H., Wolstencroft E.C., Lorson C., Bassell G.J., Burghes A.H., Beattie C.E. Survival motor neuron function in motor axons is independent of functions required for small nuclear ribonucleoprotein biogenesis. J. Neurosci. 2006, 26:11014-11022.
43. McWhorter M.L., Boon K.L., Horan E.S., Burghes A.H., Beattie C.E. The SMN binding protein Gemin2 is not involved in motor axon outgrowth. Dev. Neurobiol. 2008, 68:182-194.
44. Oprea G.E., Krober S., McWhorter M.L., Rossoll W., Muller S., Krawczak M., Bassell G.J., Beattie C.E., Wirth B. Plastin 3 is a protective modifier of autosomal recessive spinal muscular atrophy. Science 2008, 320:524-527.
45. Shankaran S.S., Capell A., Hruscha A.T., Fellerer K., Neumann M., Schmid B., Haass C. Missense mutations in the progranulin gene linked to frontotemporal lobar degeneration with ubiquitin-immunoreactive inclusions reduce progranulin production and secretion. J. Biol. Chem. 2008, 283:1744-1753.
46. Amacher S.L. Emerging gene knockout technology in zebrafish: zinc-finger nucleases. Brief Funct. Genomic Proteomic 2008, 7:460-464.
47. Dong M., Fu Y.F., Du T.T., Jing C.B., Fu C.T., Chen Y., Jin Y., Deng M., Liu T.X. Heritable and lineage-specific gene knockdown in zebrafish embryo. PLoS ONE 2009, 4:e6125.
48. Yang S.L., Yan S., Niu R.L., Lin X.K. VEGF gene silencing by cytomegalovirus promoter driven shRNA expression vector results in vascular development defects in zebrafish. Genetika 2009, 45:1187-1193.
49. Meng X., Noyes M.B., Zhu L.J., Lawson N.D., Wolfe S.A. Targeted gene inactivation in zebrafish using engineered zinc-finger nucleases. Nat. Biotechnol. 2008, 26:695-701.
50. Doyon Y., McCammon J.M., Miller J.C., Faraji F., Ngo C., Katibah G.E., Amora R., Hocking T.D., Zhang L., Rebar E.J., Gregory P.D., Urnov F.D., Amacher S.L. Heritable targeted gene disruption in zebrafish using designed zinc-finger nucleases. Nat. Biotechnol. 2008, 26:702-708.
51. Foley J.E., Yeh J.R., Maeder M.L., Reyon D., Sander J.D., Peterson R.T., Joung J.K. Rapid mutation of endogenous zebrafish genes using zinc finger nucleases made by Oligomerized Pool ENgineering (OPEN). PLoS ONE 2009, 4:e4348.
52. Wang D., Jao L.E., Zheng N., Dolan K., Ivey J., Zonies S., Wu X., Wu K., Yang H., Meng Q., Zhu Z., Zhang B., Lin S., Burgess S.M. Efficient genome-wide mutagenesis of zebrafish genes by retroviral insertions. Proc. Natl Acad. Sci. USA 2007, 104:12428-12433.
53. Moens C.B., Donn T.M., Wolf-Saxon E.R., Ma T.P. Reverse genetics in zebrafish by TILLING. Brief Funct. Genomic Proteomic 2008, 7:454-459.
54. Bassett D., Currie P.D. Identification of a zebrafish model of muscular dystrophy. Clin. Exp. Pharmacol. Physiol. 2004, 31:537-540.
55. Hall T.E., Bryson-Richardson R.J., Berger S., Jacoby A.S., Cole N.J., Hollway G.E., Berger J., Currie P.D. The zebrafish candyfloss mutant implicates extracellular matrix adhesion failure in laminin alpha2-deficient congenital muscular dystrophy. Proc. Natl Acad. Sci. USA 2007, 104:7092-7097.
56. Steffen L.S., Guyon J.R., Vogel E.D., Howell M.H., Zhou Y., Weber G.J., Zon L.I., Kunkel L.M. The zebrafish runzel muscular dystrophy is linked to the titin gene. Dev. Biol. 2007, 309:180-192.
57. Jacoby A.S., Busch-Nentwich E., Bryson-Richardson R.J., Hall T.E., Berger J., Berger S., Sonntag C., Sachs C., Geisler R., Stemple D.L., Currie P.D. The zebrafish dystrophic mutant softy maintains muscle fibre viability despite basement membrane rupture and muscle detachment. Development 2009, 136:3367-3376.
58. Langheinrich U. Zebrafish: a new model on the pharmaceutical catwalk. Bioessays 2003, 25:904-912.
59. Fishman M.C. Genomics. Zebrafish-the canonical vertebrate. Science 2001, 294:1290-1291.
60. Skromne I., Prince V.E. Current perspectives in zebrafish reverse genetics: moving forward. Dev. Dyn. 2008, 237:861-882.
61. Murphey R.D., Zon L.I. Small molecule screening in the zebrafish. Methods 2006, 39:255-261.
62. Ravikumar B., Futter M., Jahreiss L., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Narayanan U., Renna M., Jimenez-Sanchez M., Sarkar S., Underwood B., Winslow A., Rubinsztein D.C. Mammalian macroautophagy at a glance. J. Cell Sci. 2009, 122:1707-1711.
63. Ganley I.G., Lam Test H. ULK1.ATG13.FIP200 complex mediates mTOR signaling and is essential for autophagy. J. Biol. Chem. 2009, 284:12297-12305.
64. Hosokawa N., Hara T., Kaizuka T., Kishi C., Takamura A., Miura Y., Iemura S., Natsume T., Takehana K., Yamada N., Guan J.L., Oshiro N., Mizushima N. Nutrient-dependent mTORC1 association with the ULK1-Atg13-FIP200 complex required for autophagy. Mol. Biol. Cell 2009, 20:1981-1991.
65. Jung C.H., Jun C.B., Ro S.H., Kim Y.M., Otto N.M., Cao J., Kundu M., Kim D.H. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol. Biol. Cell 2009, 20:1992-2003.
66. Jacinto E., Loewith R., Schmidt A., Lin S., Ruegg M.A., Hall A., Hall M.N. Mammalian TOR complex 2 controls the actin cytoskeleton and is rapamycin insensitive. Nat. Cell Biol. 2004, 6:1122-1128.
67. Makky K., Tekiela J., Mayer A.N. Target of rapamycin (TOR) signaling controls epithelial morphogenesis in the vertebrate intestine. Dev. Biol. 2007, 303:501-513.
68. Gangloff Y.G., Mueller M., Dann S.G., Svoboda P., Sticker M., Spetz J.F., Um S.H., Brown E.J., Cereghini S., Thomas G., Kozma S.C. Disruption of the mouse mTOR gene leads to early postimplantation lethality and prohibits embryonic stem cell development. Mol. Cell. Biol. 2004, 24:9508-9516.
69. Komoike Y., Shimojima K., Liang J.S., Fujii H., Maegaki Y., Osawa M., Fujii S., Higashinakagawa T., Yamamoto T. A functional analysis of GABARAP on 17p13.1 by knockdown zebrafish. J. Hum. Genet. 2010, 55:155-162.
70. O'Sullivan G.A., Kneussel M., Elazar Z., Betz H. GABARAP is not essential for GABA receptor targeting to the synapse. Eur. J. Neurosci. 2005, 22:2644-2648.
71. Tsukamoto S., Kuma A., Murakami M., Kishi C., Yamamoto A., Mizushima N. Autophagy is essential for preimplantation development of mouse embryos. Science 2008, 321:117-120.
72. He C., Bartholomew C.R., Zhou W., Klionsky D.J. Assaying autophagic activity in transgenic GFP-Lc3 and GFP-Gabarap zebrafish embryos. Autophagy 2009, 5:520-526.
73. Ravikumar B., Sarkar S., Davies J.E., Futter M., Garcia-Arencibia M., Green-Thompson Z.W., Jimenez-Sanchez M., Korolchuk V.I., Lichtenberg M., Luo S., Massey D.C., Menzies F.M., Moreau K., Narayanan U., Renna M., Siddiqi F.H., Underwood B.R., Winslow A.R., Rubinsztein D.C. Regulation of mammalian autophagy in physiology and pathophysiology. Physiol. Rev. 2010, 90:1383-1435.
74. Dowling J.J., Low S.E., Busta A.S., Feldman E.L. Zebrafish MTMR14 is required for excitation-contraction coupling, developmental motor function and the regulation of autophagy. Hum. Mol. Genet. 2010, 19:2668-2681.
75. Vergne I., Roberts E., Elmaoued R.A., Tosch V., Delgado M.A., Proikas-Cezanne T., Laporte J., Deretic V. Control of autophagy initiation by phosphoinositide 3-phosphatase Jumpy. EMBO J. 2009, 28:2244-2258.
76. Underwood B.R., Imarisio S., Fleming A., Rose C., Krishna G., Heard P., Quick M., Korolchuk V.I., Renna M., Sarkar S., Garcia-Arencibia M., O'Kane C.J., Murphy M.P., Rubinsztein D.C. Antioxidants can inhibit basal autophagy and enhance neurodegeneration in models of polyglutamine disease. Hum. Mol. Genet. 2010, 19:3413-3429.
77. Rubinsztein D.C., Cuervo A.M., Ravikumar B., Sarkar S., Korolchuk V., Kaushik S., Klionsky D.J. In search of an "autophagomometer". Autophagy 2009, 5:585-589.
78. Ravikumar B., Duden R., Rubinsztein D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 2002, 11:1107-1117.
79. Ravikumar B., Vacher C., Berger Z., Davies J.E., Luo S., Oroz L.G., Scaravilli F., Easton D.F., Duden R., O'Kane C.J., Rubinsztein D.C. Inhibition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 2004, 36:585-595.
80. Berger Z., Ravikumar B., Menzies F.M., Oroz L.G., Underwood B.R., Pangalos M.N., Schmitt I., Wullner U., Evert B.O., O'Kane C.J., Rubinsztein D.C. Rapamycin alleviates toxicity of different aggregate-prone proteins. Hum. Mol. Genet. 2006, 15:433-442.
81. Menzies F.M., Huebener J., Renna M., Bonin M., Riess O., Rubinsztein D.C. Autophagy induction reduces mutant ataxin-3 levels and toxicity in a mouse model of spinocerebellar ataxia type 3. Brain 2010, 133:93-104.
82. Balgi A.D., Fonseca B.D., Donohue E., Tsang T.C., Lajoie P., Proud C.G., Nabi I.R., Roberge M. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS ONE 2009, 4:e7124.
83. Sarkar S., Perlstein E.O., Imarisio S., Pineau S., Cordenier A., Maglathlin R.L., Webster J.A., Lewis T.A., O'Kane C.J., Schreiber S.L., Rubinsztein D.C. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 2007, 3:331-338.
84. Zhang L., Yu J., Pan H., Hu P., Hao Y., Cai W., Zhu H., Yu A.D., Xie X., Ma D., Yuan J. Small molecule regulators of autophagy identified by an image-based high-throughput screen. Proc. Natl Acad. Sci. USA 2007, 104:19023-19028.
85. Farkas T., Hoyer-Hansen M., Jaattela M. Identification of novel autophagy regulators by a luciferase-based assay for the kinetics of autophagic flux. Autophagy 2009, 5:1018-1025.
86. Croushore J.A., Blasiole B., Riddle R.C., Thisse C., Thisse B., Canfield V.A., Robertson G.P., Cheng K.C., Levenson R. Ptena and ptenb genes play distinct roles in zebrafish embryogenesis. Dev. Dyn. 2005, 234:911-921.
87. Faucherre A., Taylor G.S., Overvoorde J., Dixon J.E., Hertog J. Zebrafish pten genes have overlapping and non-redundant functions in tumorigenesis and embryonic development. Oncogene 2008, 27:1079-1086.
88. DiBella L.M., Park A., Sun Z. Zebrafish Tsc1 reveals functional interactions between the cilium and the TOR pathway. Hum. Mol. Genet. 2009, 18:595-606.
89. http://www.ncbi.nlm.nih.gov/sites/entrez?db=nuccoreitool=toolbar.
90. http://www.ncbi.nlm.nih.gov/gene.
91. http://www.ncbi.nlm.nih.gov/bookshelf/br.fcgi?book=handbook&part=ch18&rendertype=table&id=ch18.T18.2.